Compare Edwards Lifesciences Corporation Common Stock (EW) vs Oracle Corporation (ORCL) Price & Performance

Edwards Lifesciences Corporation Common StockTrade

Oracle CorporationTrade

Price performance (Past 24H)

Key statistics

Edwards Lifesciences Corporation Common Stock vs Oracle Corporation — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.98 (market cap $48.56B), while Oracle Corporation trades at $142.25 (market cap $411.34B). The key difference: Oracle Corporation is far larger — about 8.5× Edwards Lifesciences Corporation Common Stock's market cap, and Oracle Corporation pays a 1.47% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.

	EW	ORCL
Market Cap	$48.56B	$411.34B
Volume	6,520,488	41,276,815
Sector	Health	Technology
52-Week High	$95.18	$313.00
52-Week Low	$72.65	$114.99
Enterprise Value	$45.01B	$535.15B
Typical Hold Time	—	72 Days
Dividend Yield	—	1.47%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Edwards Lifesciences Corporation Common Stock

No Aura AI signal available yet.

Oracle Corporation

Oracle (ORCL) trades at $143.56, down 0.83% amid a bearish technical signal, though recent earnings consistently beat expectations with Q2 2026 EPS of $1.92 versus $1.74 expected. The company shows strong fundamentals with 2025 revenue of $57.40B and net income margin of 26.36%, while analyst consensus remains bullish with a $236.52 price target. News highlights AI cloud growth of 120% in Q1 2026 but also layoffs and market concerns over AI spending cycles.

The outlook is mixed: robust AI-driven revenue growth and high profitability support upside, but technical weakness and macroeconomic risks like Fed policy pose near-term headwinds. Investors face opportunity from AI demand against volatility from high debt and competitive pressures.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

No sentiment data available yet.

ORCL

57% Buy43% Sell

Avg holding period · 72 Days

Top news

Latest headlines on both assets

View details →

ORCL

Odds rise to 75% for over 5,100 AI data centers by 2027 despite public backlashCNBC · 7 hours agoNeutral Oracle stock seen with 49% upside as cloud backlog signals strong growth despite recent lows.24/7 Wall Street · 7 hours agoBullish Oracle reaffirmed as a buy with 30% revenue growth and strong cloud demand, despite high leverage.Seeking Alpha · 8 hours agoBullish View details →

About Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.